Cargando…
Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
The local, intramyocardial injection of proteins into the infarcted heart is an attractive option to initiate cardiac regeneration after myocardial infarction (MI). Liraglutide, which was developed as a treatment for type 2 diabetes, has been implicated as one of the most promising protein candidate...
Autores principales: | Qi, Quan, Lu, Lei, Li, Haiqing, Yuan, Zhize, Chen, Gaoxian, Lin, Miao, Ruan, Zhengwen, Ye, Xiaofeng, Xiao, Zeyu, Zhao, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511023/ https://www.ncbi.nlm.nih.gov/pubmed/28744119 http://dx.doi.org/10.2147/IJN.S132064 |
Ejemplares similares
-
Recent Advances in Nanoformulations for Quercetin Delivery
por: Tomou, Ekaterina-Michaela, et al.
Publicado: (2023) -
Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies
por: Kaps, Anna, et al.
Publicado: (2021) -
Microbial Polysaccharide-Based
Nanoformulations for
Nutraceutical Delivery
por: Srivastava, Nandita, et al.
Publicado: (2022) -
Cardiac Regeneration After Myocardial Infarction: an Approachable Goal
por: Giacca, Mauro
Publicado: (2020) -
Comparative manufacture and cell-based delivery of antiretroviral nanoformulations
por: Balkundi, Shantanu, et al.
Publicado: (2011)